CHARACTERISTICS
ACTIVE HALF-LIFE: 36 HOURS
CLASSIFICATION: PDE5 INHIBITOR
DOSAGE: MEN 20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: POSSIBLE
HEPATOTOXICITY: NO
AROMATIZATION: NO
ACTIVE SUBSTANCE: TADALAFIL
FORM: 50 PILLS X 20 MG
MANUFACTURER: PARA PHARMA
DISEASE INDICATIONS: Atopic Dermatitis
MANUFACTURER: Pfizer Limited
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Medicines & Healthcare products Regulatory Agency (MHRA)
Cibinqo (abrocitinib) is a prescription medicine used to treat adults and children 12 years of age and older with moderate-to-severe atopic dermatitis (eczema) that did not respond to other treatment and is not well controlled with prescription medicines, including biologics, or when they cannot be tolerated.
CHARACTERISTICS
ACTIVE HALF-LIFE 48-72 HOURS
CLASSIFICATION BETA-2 AGONIST, BRONCHODILATOR
DOSAGE 80-140 MCG/DAY
ACNE NO
WATER RETENTION NO
HBR NO
HEPATOTOXICITY NO
AROMATIZATION NO
ACTIVE SUBSTANCE CLENBUTEROL
FORM 50 PILLS X 20 MCG
MANUFACTURER SOPHARMA
CHARACTERISTICS
ACTIVE HALF-LIFE 48-72 HOURS
CLASSIFICATION BETA-2 AGONIST, BRONCHODILATOR
DOSAGE 80-140 MCG/DAY
ACNE NO
WATER RETENTION NO
HBR NO
HEPATOTOXICITY NO
AROMATIZATION NO
ACTIVE SUBSTANCE CLENBUTEROL
FORM 100 PILLS X 40 MCG
MANUFACTURER DRAGON PHARMA
DISEASE INDICATIONS: Amyotrophic Lateral Sclerosis (ALS)
MANUFACTURER: Harasawa
USAGE: Oral
MEDICINE APPROVED BY:
Pharmaceuticals and Medical Devices Agency (PMDA)
Clenbuterol, a medication employed in the management of individuals afflicted with bronchial asthma, chronic bronchitis, emphysema, acute bronchitis, or stress urinary incontinence, has diverse applications in the medical field.
Notably, physicians occasionally opt for Clenbuterol's off-label use in the treatment of patients grappling with ALS (Amyotrophic Lateral Sclerosis).
It's worth mentioning that Clenbuterol was previously recognized by its brand name, TONIL (clenbuterol).
